Tadalafil

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3555 publications

Real-world outcomes of tadalafil plus mirabegron combination therapy in men with lower urinary tract symptoms and overactive bladder symptoms: a retrospective cohort study.

Real-world outcomes of tadalafil plus mirabegron combination therapy in men with lower urinary tract symptoms and overactive bladder symptoms: a retrospective cohort study.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: March 25, 2026

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: March 24, 2026

Effect of 6-week tadalafil treatment on blood-based biomarkers of neurodegeneration: A post-hoc analysis of a randomized controlled trial.

Effect of 6-week tadalafil treatment on blood-based biomarkers of neurodegeneration: A post-hoc analysis of a randomized controlled trial.

Journal: Journal of Alzheimer's disease : JAD

Published: March 13, 2026

Unrepaired Truncus Arteriosus Type 1 With Eisenmenger Syndrome and Recurrent Embolic Strokes: An Adult Case Report.

Unrepaired Truncus Arteriosus Type 1 With Eisenmenger Syndrome and Recurrent Embolic Strokes: An Adult Case Report.

Journal: The American journal of case reports

Published: March 11, 2026

Corrigendum to "Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)" [Vascular Pharmacology 162 (2026) 107585].

Corrigendum to "Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)" [Vascular Pharmacology 162 (2026) 107585].

Journal: Vascular pharmacology

Published: February 26, 2026

High-Altitude Pulmonary Edema Management in a Special Operator.

High-Altitude Pulmonary Edema Management in a Special Operator.

Journal: Journal of special operations medicine : a peer reviewed journal for SOF medical professionals

Published: February 22, 2026

Diagnostic Uncertainty in a Patient With Late-Onset Hypogonadism-Like Symptoms: A Case Report.

Diagnostic Uncertainty in a Patient With Late-Onset Hypogonadism-Like Symptoms: A Case Report.

Journal: Cureus

Published: February 18, 2026

Tadalafil and tamsulosin in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: A prospective, randomized, open-label, comparative study.

Tadalafil and tamsulosin in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: A prospective, randomized, open-label, comparative study.

Journal: Urologia

Published: February 15, 2026

Dopamine receptors: Potential therapeutic targets for ischemia-reperfusion injury: A review.

Dopamine receptors: Potential therapeutic targets for ischemia-reperfusion injury: A review.

Journal: International journal of biological macromolecules

Published: February 14, 2026

Comparison of Safety and Efficacy of Avanafil and Tadalafil in the Treatment of Erectile Dysfunction: A Prospective Observational Study.

Comparison of Safety and Efficacy of Avanafil and Tadalafil in the Treatment of Erectile Dysfunction: A Prospective Observational Study.

Journal: Cureus

Published: February 13, 2026

Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.

Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.

Journal: BJU international

Published: February 10, 2026

Efficacy and Safety of Tofacitinib Compared to Cyclophosphamide in Early Diffuse Cutaneous Systemic Sclerosis: A Randomized Controlled Trial.

Efficacy and Safety of Tofacitinib Compared to Cyclophosphamide in Early Diffuse Cutaneous Systemic Sclerosis: A Randomized Controlled Trial.

Journal: Cureus

Published: February 05, 2026

Showing 1-12 of 3,555

Last Updated: 04/28/2026